News

Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Japanese Patients 60 Years or Older With Atherosclerotic Risk Factors

26.11.20141778

Prevention of atherosclerotic cardiovascular diseases is an important public health priority in Japan due to an aging population.

?-Blockers and Cardiovascular Events in Patients With and Without Myocardial Infarction

25.11.20141694

The long-term efficacy of ?-blockers in patients with and without myocardial infarction (MI) is controversial.

Patients with treatment-resistant arterial hypertension had significant reductions in office-measured and ambulatory BP following arteriovenous anastomosis with a mechanical device, according to results from the CONTROL-HTN study presented at VIVA 14

21.11.20140

Researchers for the prospective, controlled, blinded, multicenter study evaluated 83 patients with treatment-resistant hypertension.

Association of Inpatient vs. Outpatient Onset of ST-Elevation Myocardial Infarction With Treatment and Clinical Outcomes

20.11.20141733

What are the incidence and variables associated with treatment and outcomes of patients with inpatient-onset ST-segment elevation myocardial infarction (STEMI)?

What is the Long-Term Cause of Death in STEMI Patients Treated With Primary PCI?

19.11.20141931

The risk of cardiac mortality declines to less than 1.5 percent per year following survival after a ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI), and noncardiac causes are responsible for the majority of later deaths in these patients, according to a study published Nov. 10 in the Journal of the American College of Cardiology.

The QT Interval Is Associated With Incident Cardiovascular Events: The MESA Study

18.11.20142175

Study Question: Is the baseline QT interval predictive of negative cardiovascular outcomes?

Study Examines Follow-Ups in Adolescents With Family History of Brugada Syndrome

17.11.20141616

В соответствии с исследованием, опубликованным 16 ноября в журнале Американской медицинской ассоциации, у пациентов с семейным анамнезом синдрома Бругада и отрицательным результатом теста, проведенным в детстве, синдром может развиться в последующей жизни в результате действия гормональных, вегетативных или генетических факторов.